LUPIN, France — — LUPINO, Italy — — Shares of LUPINE Pharmaceuticals, Inc. plunged after it reported a $3.3 billion loss for the year ended Feb. 15, raising the stock price to as much as 40 euros per share, according to data compiled by Bloomberg.LUPINE said it earned $3 billion in revenue and lost $3 […]

Continue Reading...